NCT02756637 2023-08-07Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710Abramson Cancer Center at Penn MedicineCompleted634 enrolled 6 charts
NCT03063125 2021-08-03Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder CancerUniversity of Kansas Medical CenterCompleted25 enrolled 9 charts
NCT01166230 2019-04-09Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURBPhotocureCompleted551 enrolled 8 charts
NCT01637935 2018-03-07Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II DiabetesTakedaCompleted193,099 enrolled 15 charts
NCT01236053 2017-07-06Cancer in Patients With Gabapentin (GPRD)GlaxoSmithKlineCompleted2,323,608 enrolled 86 charts
NCT01444456 2017-03-20Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced AnaemiaAmgenCompleted1,262 enrolled 14 charts
NCT02233842 2016-09-12Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and SurvivorsNational Institutes of Health Clinical Center (CC)Completed30 enrolled 13 charts
NCT00634621 2014-08-25Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder CancerGE HealthcareCompleted283 enrolled 6 charts